ITEM 1.02. TERMINATION OF A MATERIAL DEFINITIVE AGREEMENT.

On December 22, 2008, Ivivi Technologies, Inc. (the "Company") received notification from DSI Renal, Inc. ("DSI") that DSI has terminated the collaboration agreement (the "Agreement"), dated February 11, 2008, between the Company and DSI. In its letter, DSI notified the Company that it has ceased the operation of its clinical research division and is no longer sponsoring or engaging in clinical research activities. The Company currently is reviewing whether DSI's termination of the Agreement is in accordance with the terms thereof.

Pursuant to the Agreement, DSI was required to use its best efforts to conduct clinical research trials (collectively, the "Clinical Trials") utilizing certain of the Company's products (collectively, the "Products") on DSI's patients with end-stage renal disease. DSI was also required to conduct multi-site clinical trials at DSI's clinics in the field of cardiovascular disease using protocols mutually agreed to by the Company and DSI (collectively, the "Multi-Site Trials"). The Agreement also contemplated that the Products would be introduced to DSI's clinics in accordance with the terms thereof. As of the date of termination of the Agreement, DSI had not conducted any of the Clinical Trials or the Multi-Site Trials and had not introduced the Products into any of its clinics. The term of the Agreement commenced on February 11, 2008 and was for a period of seven and one-half years.